It’s a moral imperative that money spent on global health be used as effectively as possible to prevent and treat diseases and save lives. But sound investments in global health are defined in many ways: a cost-effective commodity or technology, a well-trained health workforce, or an evidence-informed policy. This event will convene experts from implementing agencies, governments, researcher institutions, and the private sector to discuss and debate what makes a “best buy” in global health.
The first panel will explore the enabling elements that help health interventions succeed – such as a favorable regulatory environment, a functioning health system, political will, and donor support – and debate why interventions have succeeded in some contexts and not others. The second panel will highlight examples of specific global health interventions being deployed by donors and governments, and discuss why – or why not – they are a good investment based on considerations of innovation, health impact, cost-effectiveness, and sustainability.